<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="aec" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">aec</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">TP63</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sutton</surname>
            <given-names>V Reid</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor, Department of Molecular and Human Genetics<break/>Baylor College of Medicine &#x00026; Texas Children&#x02019;s Hospital<break/>Houston, Texas</aff>
          <email>vrsutton@texaschildrens.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van Bokhoven</surname>
            <given-names>Hans</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Professor, Molecular Neurogenetics<break/>Department of Human Genetics<break/>Radboud University Medical Center<break/>Nijmegen, The Netherlands</aff>
          <email>hans.vanbokhoven@radboudumc.nl</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2010-06-08" date-type="created">
          <day>8</day>
          <month>6</month>
          <year>2010</year>
        </date>
        <date iso-8601-date="2015-08-06" date-type="updated">
          <day>6</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="tk2-mtddepl" document-type="chapter"><italic toggle="yes">TK2</italic>-Related Mitochondrial DNA Depletion Syndrome, Myopathic Form</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="trio-id" document-type="chapter"><italic toggle="yes">TRIO</italic>-Related Intellectual Disability</related-object>
      <abstract id="aec.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The <italic toggle="yes">TP63</italic>-related disorders comprise six overlapping phenotypes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome (which includes Rapp-Hodgkin syndrome)</p>
            </list-item>
            <list-item>
              <p>Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome</p>
            </list-item>
            <list-item>
              <p>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</p>
            </list-item>
            <list-item>
              <p>Limb-mammary syndrome</p>
            </list-item>
            <list-item>
              <p>Split-hand/foot malformation type 4 (SHFM4)</p>
            </list-item>
            <list-item>
              <p>Isolated cleft lip/cleft palate (orofacial cleft 8)</p>
            </list-item>
          </list>
          <p>Individuals typically have varying combinations of ectodermal dysplasia (subjective hypohidrosis, nail dysplasia, sparse hair, tooth abnormalities), cleft lip/palate, split-hand/foot malformation/syndactyly, lacrimal duct obstruction, hypopigmentation, and hypoplastic breasts and/or nipples. Findings associated with a single phenotype include ankyloblepharon filiforme adnatum (tissue strands that completely or partially fuse the upper and lower eyelids), skin erosions especially on the scalp associated with areas of scarring and alopecia, hypospadias, trismus, and excessive freckling.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is based on clinical findings and molecular genetic testing of <italic toggle="yes">TP63</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> A multidisciplinary team of specialists in clinical genetics, dermatology, ophthalmology, otolaryngology, audiology, dentistry and prosthodontics, plastic surgery, gastroenterology, and psychiatry is recommended. Wigs can be used for sparse hair and alopecia; dentures may be considered in early childhood and dental implants in the teens or early adulthood. Skin erosions are treated with gentle wound care and periodic, dilute bleach soaks to prevent secondary infection. Cleft lip/palate is managed as per routine protocols with attention to feeding in infancy, recurrent otitis media, and speech therapy.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Infants with severe skin erosions need aggressive monitoring/treatment of dehydration, electrolyte imbalances, malnutrition, and secondary infection and sepsis.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular evaluation with a multidisciplinary team with attention to dental needs and possible hearing loss.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>The <italic toggle="yes">TP63</italic>-related disorders are inherited in an autosomal dominant manner. Approximately 30% of individuals have an affected parent and approximately 70% have a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with a <italic toggle="yes">TP63</italic>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the <italic toggle="yes">TP63</italic> pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="aec.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="aec.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_aec.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">TP63</italic>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_aec.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC syndrome)</p>
                      <list list-type="bullet">
                        <list-item>
                          <p>Rapp-Hodgkin syndrome</p>
                        </list-item>
                      </list>
                    </list-item>
                    <list-item>
                      <p>Acro-dermo-ungual-lacrimal-tooth syndrome (ADULT syndrome)</p>
                    </list-item>
                    <list-item>
                      <p>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</p>
                    </list-item>
                    <list-item>
                      <p>Limb-mammary syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Split-hand/foot malformation type 4 (SHFM4)</p>
                    </list-item>
                    <list-item>
                      <p>Isolated cleft lip/cleft palate (orofacial cleft 8)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="aec.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="aec.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes, see <xref ref-type="sec" rid="aec.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="aec.Diagnosis">
        <title>Diagnosis</title>
        <sec id="aec.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><bold>The <italic toggle="yes">TP63</italic>-related disorders</bold> include the following overlapping phenotypes (summarized in <xref ref-type="table" rid="aec.T.clinical_features_of_tp63related_d">Table 1</xref>).</p>
          <p>
            <bold>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ankyloblepharon filiforme adnatum typically manifest as strands of tissue that completely or partially fuse the upper and lower eyelids. In the latter instance, they may be barely perceptible and lyse spontaneously. Although a definitive part of the syndrome, ankyloblepharon may not be present or detected in up to 50% of cases.</p>
            </list-item>
            <list-item>
              <p>Ectodermal defects typically manifest as sparse wiry hair, skin erosions and unique pigmentary skin changes, nail changes, dental changes, and subjective decrease in sweating capacity. Note: (1) Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability. (2) Scalp erosions are characteristic of AEC syndrome and are NOT seen in other <italic toggle="yes">TP63-</italic>related disorders.</p>
            </list-item>
            <list-item>
              <p>Cleft lip/palate presents in nearly 100%; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate. In a series of 18 affected individuals: 44% had cleft lip (~1/3 bilateral); 100% had some form of palatal cleft (cleft hard palate: 56%; cleft soft palate: 89%; submucous cleft palate: 17%).</p>
            </list-item>
            <list-item>
              <p>Craniofacial findings include the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Maxillary hypoplasia (reported in 94%)</p>
                </list-item>
                <list-item>
                  <p>Small mandible (reported in 65%)</p>
                </list-item>
                <list-item>
                  <p>Broad nasal bridge (76%)</p>
                </list-item>
                <list-item>
                  <p>Hypoplastic alae nasi (94%)</p>
                </list-item>
                <list-item>
                  <p>Thin vermilion border of the upper lip (82%)</p>
                </list-item>
                <list-item>
                  <p>Microstomia (94%)</p>
                </list-item>
                <list-item>
                  <p>Trismus (44%)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Hypospadias has been reported in 80% of males.</p>
            </list-item>
          </list>
          <p>Note: Rapp-Hodgkin syndrome (RHS), once thought to be a separate entity, is now considered to be part of the spectrum of the AEC syndrome because of the overlap of clinical manifestations and <italic toggle="yes">TP63</italic> pathogenic variants observed in the two conditions [<xref ref-type="bibr" rid="aec.REF.cambiaghi.1994.97">Cambiaghi et al 1994</xref>, <xref ref-type="bibr" rid="aec.REF.bertola.2004.79">Bertola et al 2004</xref>].</p>
          <p>
            <bold>Acro-dermo-ungual-lacrimal-tooth (ADULT) syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Acromelic malformation is present in the form of split hand and/or split foot with or without syndactyly.</p>
            </list-item>
            <list-item>
              <p>Dermatologic abnormalities include sparse fine hair; dry skin, and unique pigmentary skin changes.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Excessive freckling in sun-exposed areas is common and progresses with age and sun exposure. It is unique to ADULT syndrome and not characteristic of other <italic toggle="yes">TP63&#x02013;</italic>related disorders.</p>
                </list-item>
                <list-item>
                  <p>There may be subjective decrease in sweating capacity. Note: Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Ungual defects manifest as hypoplastic, dysplastic, absent, and/or ridged nails.</p>
            </list-item>
            <list-item>
              <p>Lacrimal puncta absence is seen in many affected individuals.</p>
            </list-item>
            <list-item>
              <p>Tooth abnormalities include hypodontia or oligodontia.</p>
            </list-item>
            <list-item>
              <p>Breast and/or nipple hypoplasia that may be symmetric or asymmetric is typically seen in ADULT syndrome and limb-mammary syndrome and not in other <italic toggle="yes">TP63-</italic>related disorders.</p>
            </list-item>
          </list>
          <p>
            <bold>Ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Ectrodactyly (now referred to as split-hand/foot malformation) with or without syndactyly is present in approximately 70% of all affected individuals and ranges widely in severity and location of the digital abnormalities [<xref ref-type="bibr" rid="aec.REF.rinne.2006.1396">Rinne et al 2006a</xref>].</p>
            </list-item>
            <list-item>
              <p>Ectodermal defects typically manifest as silvery-blond, sparse fine hair; dry skin and unique pigmentary skin changes; nail changes; dental changes including oligodontia and enamel defects; and xerostomia and subjective decrease in sweating capacity. Note: Starch iodide sweat testing of the palms is rarely helpful in documenting sweating ability.</p>
            </list-item>
            <list-item>
              <p>Cleft lip/palate is present in approximately 40% of affected individuals [<xref ref-type="bibr" rid="aec.REF.rinne.2006.1396">Rinne et al 2006a</xref>]; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</p>
            </list-item>
            <list-item>
              <p>Other</p>
              <list list-type="bullet">
                <list-item>
                  <p>Absent lacrimal puncta is seen in almost all affected individuals.</p>
                </list-item>
                <list-item>
                  <p>Blepharophimosis is seen occasionally.</p>
                </list-item>
                <list-item>
                  <p>Hypospadias has been reported often in males.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Limb-mammary syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Limb abnormalities can include split-hand/foot malformation, oligodactyly, and syndactyly.</p>
            </list-item>
            <list-item>
              <p>Breast and/or nipple hypoplasia has been reported in 90% of individuals with limb-mammary syndrome [<xref ref-type="bibr" rid="aec.REF.van_bokhoven.1999.538">van Bokhoven et al 1999</xref>]. It may be symmetric or asymmetric, and is typical for ADULT syndrome and limb-mammary syndrome and rarely seen in other <italic toggle="yes">TP63-</italic>related disorders.</p>
            </list-item>
            <list-item>
              <p>Less common findings</p>
              <list list-type="bullet">
                <list-item>
                  <p>Absent lacrimal puncta and lacrimal duct atresia is seen in half of all affected individuals.</p>
                </list-item>
                <list-item>
                  <p>Cleft lip/palate is present in one quarter to one third of affected individuals; the spectrum includes submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</p>
                </list-item>
                <list-item>
                  <p>Hypodontia and nail dysplasia is found in a small percentage of individuals; skin and hair abnormalities are NOT seen.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Split-hand/foot malformation type 4 (SHFM4)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Split hand/foot with or without syndactyly is present in all affected individuals and ranges widely in severity and location of renal abnormalities. Aplasia or hypoplasia of phalanges and metacarpals is seen.</p>
            </list-item>
            <list-item>
              <p>Ectodermal abnormalities and cleft lip/palate are very rarely seen.</p>
            </list-item>
          </list>
          <p>
            <bold>Isolated cleft lip/cleft palate (orofacial cleft 8)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cleft lip/palate includes a wide spectrum ranging from submucous cleft palate only to cleft of the soft and/or the hard palate only, cleft lip only, and the combination of cleft lip and cleft palate.</p>
            </list-item>
          </list>
          <table-wrap id="aec.T.clinical_features_of_tp63related_d" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Clinical Features of <italic toggle="yes">TP63</italic>-Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1">Feature</th>
                  <th id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" valign="middle" colspan="6" align="left" scope="colgroup" rowspan="1"><italic toggle="yes">TP63</italic>-Related Disorder</th>
                </tr>
                <tr>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">AEC</th>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ADULT</th>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">EEC3</th>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Limb-Mammary</th>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">SHFM4</th>
                  <th headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2" id="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" scope="col" rowspan="1" colspan="1">Isolated CL/P</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Ankyloblepharon filiforme adnatum</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Ectodermal dysplasia</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1">Rare</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>
                          <bold>Hypohidrosis (mostly subjective)</bold>
                        </p>
                      </list-item>
                    </list>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>
                          <bold>Nail dysplasia</bold>
                        </p>
                      </list-item>
                    </list>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">Mild</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>
                          <bold>Sparse hair</bold>
                        </p>
                      </list-item>
                    </list>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Tooth abnormalities</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cleft lip/palate</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1">X</td>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Split-hand/foot malformation/syndactyly</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Lacrimal duct obstruction</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Dermal erosions</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hypopigmentation</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hypospadias</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Trismus</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Excessive freckling</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hypoplastic breasts</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Hypoplastic nipples</bold>
                  </td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_2" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_3" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_4" valign="top" align="left" rowspan="1" colspan="1">X</td>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_5" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_aec.T.clinical_features_of_tp63related_d_1_1_1_2 hd_h_aec.T.clinical_features_of_tp63related_d_1_1_2_6" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>ADULT = acro-dermato-ungual-lacrimal-tooth</p>
              </fn>
              <fn>
                <p>EEC = ectrodactyly (split-hand/foot malformation), ectodermal dysplasia, clefting</p>
              </fn>
              <fn>
                <p>SHFM4 = split-hand/foot malformation type 4</p>
              </fn>
              <fn>
                <p>CL/P = cleft lip/cleft palate</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="aec.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">TP63</italic>-related disorder is established by identification of a <italic toggle="yes">TP63</italic> heterozygous pathogenic variant in a proband on molecular genetic testing (see <xref ref-type="table" rid="aec.T.summary_of_molecular_genetic_testi">Table 2</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">TP63</italic> is performed first followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">TP63</italic> and other genes of interest (see <xref ref-type="sec" rid="aec.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included in multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="aec.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">TP63</italic> Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TP63</italic>
                  </td>
                  <td headers="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">75%-100%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_aec.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Rare&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="aec.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="aec" object-id="aec.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="aec.TF.2.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="aec.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="aec.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="aec.TF.2.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="aec.REF.van_bokhoven.2001.481">van Bokhoven et al [2001]</xref>, <xref ref-type="bibr" rid="aec.REF.rinne.2009.1948">Rinne et al [2009]</xref></p>
              </fn>
              <fn id="aec.TF.2.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="aec.TF.2.6">
                <label>6. </label>
                <p>A single case report of a four-exon deletion of <italic toggle="yes">TP63</italic> has been reported in an individual with EEC [<xref ref-type="bibr" rid="aec.REF.aradhya.2012.594">Aradhya et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="aec.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="aec.Clinical_Description">
          <title>Clinical Description</title>
          <sec id="aec.AEC_Syndrome">
            <title>AEC Syndrome</title>
            <p>The manifestations of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome are typically present at birth.</p>
            <p><bold>Ankyloblepharon</bold> is present in 70% of neonates. While the upper- and lower-eyelid adhesions can be obvious, partial adhesion of the upper and lower eyelids can be subtle and these filiforme adhesions can spontaneously lyse before they are recognized as such.</p>
            <p>Lacrimal puncta are frequently absent, often leading to chronic conjunctivitis and blepharitis which is often not recognized in infancy but rather seen in early childhood [<xref ref-type="bibr" rid="aec.REF.sutton.2009.1916">Sutton et al 2009</xref>].</p>
            <p>
              <bold>Ectodermal defects</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Skin.</bold> Nearly 100% of affected neonates have superficial skin erosions that vary from very limited to severe, life-threatening full-body involvement. The erosions most typically affect the scalp at birth and during infancy. Severe scalp erosions often lead to scarring alopecia and hypotrichosis. This is NOT seen in other <italic toggle="yes">TP63-</italic>related disorders.The skin erosions tend to be recurrent and intermittent throughout childhood and into adulthood with frequent involvement of the head and neck, palms, soles, and skin folds. Congenital erythroderma (i.e. diffuse erythema with associated erosions) is observed in 70%-90% of infants. The skin can also appear shiny with a collodion membrane (red, shiny, membranous skin changes) [<xref ref-type="bibr" rid="aec.REF.siegfried.2005.1591">Siegfried et al 2005</xref>]. Children typically manifest cutaneous depigmentation and scarring, most likely due to postinflammatory pigmentary changes related to previous erythroderma and associated underlying erosions which may or may not be appreciated clinically. African American infants can have facial hypopigmentation in a mask pattern that improves with age. Affected individuals with fair skin typically have a reticulated hyperpigmentation on the neck and intertriginous areas that progresses with age to cribiform, reticulate, stellate, or punctate scarring most commonly on the shoulders, upper back, and chest.Histopathologic features of skin biopsies may reveal epidermal atrophy, pigment incontinence, and a prominent superficial perivascular plexus with limited lymphocytic infiltrate [<xref ref-type="bibr" rid="aec.REF.dishop.2009.1935">Dishop et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Hair changes</bold> become more obvious with age. Hair is typically light-colored and coarse, wiry, and brittle with a spun glass/gold or &#x0201c;uncombable&#x0201d; appearance. Eyebrows and eyelashes are sparse. Light and scanning microscopy may reveal structural and pigmentary alterations of the hair including kinking, grooves, and discontinuous pigmentation.</p>
              </list-item>
              <list-item>
                <p><bold>Nail</bold>
<bold>changes,</bold> present in all and more obvious with age, vary among individuals. Most affected individuals have nail dystrophy (abnormal nail plate texture) and hyperconvex nail plates. Micronychia (abnormally small nail plates), distal frayed edges with nail plate resorption, and absent nails are also frequent [<xref ref-type="bibr" rid="aec.REF.julapalli.2009.1900">Julapalli et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Dental anomalies.</bold> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence. Affected adults have an average of 4.75 secondary teeth [<xref ref-type="bibr" rid="aec.REF.farrington.2009.1907">Farrington &#x00026; Lausten 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Sweating.</bold> Subjective decreased sweat production is universal and is reported as heat intolerance; however, this does <bold>not</bold> lead to hyperthermia or fevers as seen in <related-object link-type="booklink" source-id="gene" document-id="x-hed" document-type="chapter">hypohidrotic ectodermal dysplasia</related-object>.</p>
              </list-item>
            </list>
            <p><bold>Clefting</bold> is present in all. Clefting can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate [<xref ref-type="bibr" rid="aec.REF.cole.2009.1910">Cole et al 2009</xref>].</p>
            <p><bold>Other</bold> findings include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Limb anomalies</bold> were initially not considered to be part of the syndrome, but syndactyly of fingers and toes and/or camptodactyly (permanent and irreducible flexion of the fingers) of hands have been seen. Split-hand/foot malformation was observed in 2/17 individuals (12%) with AEC syndrome [<xref ref-type="bibr" rid="aec.REF.sutton.2009.1916">Sutton et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Hypospadias</bold> has been reported in 78% of males with AEC syndrome [<xref ref-type="bibr" rid="aec.REF.sutton.2009.1916">Sutton et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Facial features</bold> become more distinctive with age. Findings commonly include maxillary hypoplasia, micrognathia, broad nasal root, underdeveloped alae nasi, thin vermilion of the upper lip, and short philtrum.</p>
              </list-item>
              <list-item>
                <p><bold>Trismus</bold> has been reported in 35% of individuals with AEC syndrome [<xref ref-type="bibr" rid="aec.REF.sutton.2009.1916">Sutton et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Hearing loss.</bold> More than 90% of children have conductive hearing loss, often with secondary speech delay [<xref ref-type="bibr" rid="aec.REF.cole.2009.1910">Cole et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Growth.</bold> Poor weight gain and failure to thrive should be anticipated. When treated appropriately with nutritional supplementation poor weight gain improves with age.Linear growth abnormalities are observed in early childhood with a significantly lower height for age compared to the reference population. The growth pattern in AEC is similar to that reported for hypohidrotic ectodermal dysplasia [<xref ref-type="bibr" rid="aec.REF.motil.2009.1922">Motil &#x00026; Fete 2009</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Psychological impact</bold> related to the phenotypic features of the disease can include a reduced quality of life with negative impact on both child and family. In one study, a variable degree of psychological functioning was noted with some families reporting few ill effects from the disease while others reported significant impact [<xref ref-type="bibr" rid="aec.REF.lane.2009.1926">Lane et al 2009</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="aec.ADULT_Syndrome">
            <title>ADULT Syndrome</title>
            <p>The manifestations of acro-dermato-ungual-lacrimal-tooth (ADULT) syndrome are typically present at birth (although they may become more prominent with age), with the exception of skin freckling.</p>
            <p><bold>Limb anomalies.</bold> Most commonly seen is syndactyly of fingers and toes.</p>
            <p>
              <bold>Ectodermal defects</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Skin</bold> tends to be dry but erosions are not present.</p>
              </list-item>
              <list-item>
                <p><bold>Hair changes</bold> are more obvious with age. Hair is typically light-colored and fine. Eyebrows and eyelashes are sparse.</p>
              </list-item>
              <list-item>
                <p><bold>Nail dysplasia</bold> is commonly reported.</p>
              </list-item>
              <list-item>
                <p><bold>Dental anomalies.</bold> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence.</p>
              </list-item>
              <list-item>
                <p><bold>Sweating.</bold> Subjective decreased sweat production is universal and is reported as heat intolerance; however, this does <bold>not</bold> lead to hyperthermia or fevers as seen in <related-object link-type="booklink" source-id="gene" document-id="x-hed" document-type="chapter">hypohidrotic ectodermal dysplasia</related-object>.</p>
              </list-item>
            </list>
            <p><bold>Lacrimal duct atresia</bold> is frequent and often leads to chronic conjunctivitis and blepharitis, which are often not recognized until early childhood [<xref ref-type="bibr" rid="aec.REF.sutton.2009.1916">Sutton et al 2009</xref>].</p>
            <p><bold>Breast and/or nipple hypoplasia</bold> is seen commonly and most notably in females. This feature is characteristic of ADULT and limb-mammary syndrome and NOT typically seen in other <italic toggle="yes">TP63-</italic>related disorders.</p>
            <p><bold>Excessive freckling</bold> in sun exposed areas is seen in a subset of patients and progresses with age and sun exposure. This feature is NOT seen in other <italic toggle="yes">TP63-</italic>related disorders.</p>
          </sec>
          <sec id="aec.EEC3_Syndrome">
            <title>EEC3 Syndrome</title>
            <p>The manifestations of ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome 3 (EEC3) are typically present at birth.</p>
            <p><bold>Limb anomalies</bold> are seen in 68%-90% of individuals with 60% having tetramelic involvement. A wide variety of limb abnormalities are reported including syndactyly, oligodactyly, split-hand/foot malformation and digital duplication. A cohort of 152 EEC syndrome patients showed split-hand/foot malformation in 68% and syndactyly in 43% [<xref ref-type="bibr" rid="aec.REF.rinne.2006.1396">Rinne et al 2006a</xref>].</p>
            <p>
              <bold>Ectodermal defects</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Skin</bold> tends to be dry but erosions are not present.</p>
              </list-item>
              <list-item>
                <p><bold>Hair changes</bold> become more obvious with age and are seen in 60%-80% of individuals with EEC syndrome [<xref ref-type="bibr" rid="aec.REF.rinne.2006.1396">Rinne et al 2006a</xref>]. Hair is typically silvery-blond, coarse, and dry; 20% have sparse hair. Light microscopy has been reported to be normal in EEC syndrome [<xref ref-type="bibr" rid="aec.REF.pashayan.1974.105">Pashayan et al 1974</xref>]. Eyebrows and eyelashes are sparse.</p>
              </list-item>
              <list-item>
                <p><bold>Nail</bold>
<bold>dysplasia</bold> is commonly reported.</p>
              </list-item>
              <list-item>
                <p><bold>Dental anomalies.</bold> Malformed teeth (conical shape with small occlusal tables) and hypodontia (reduced number of teeth) also become evident during childhood and adolescence.</p>
              </list-item>
              <list-item>
                <p><bold>Sweating.</bold> Hypohidrosis is uncommon in EEC3 syndrome.</p>
              </list-item>
            </list>
            <p><bold>Cleft lip with or without cleft palate</bold> is present in 60%-75% and is bilateral in half of cases. Clefting can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate [<xref ref-type="bibr" rid="aec.REF.buss.1995.716">Buss et al 1995</xref>].</p>
            <p><bold>Absent lacrimal puncta</bold> is reported in 90% of individuals and results in tearing, blepharitis, dacryocystitis, keratoconjunctivitis and photophobia and often lead to corneal ulceration and scaring [<xref ref-type="bibr" rid="aec.REF.buss.1995.716">Buss et al 1995</xref>].</p>
            <p><bold>Genitourinary malformations</bold> are reported in 45% and may include hypospadias and developmental abnormalities of the kidneys and urinary collecting system.</p>
          </sec>
          <sec id="aec.LimbMammary_Syndrome">
            <title>Limb-Mammary Syndrome</title>
            <p>The manifestations limb-mammary syndrome are typically present at birth.</p>
            <p><bold>Limb anomalies,</bold> including split-hand/foot malformation and syndactyly are reported in 75%-85% of individuals.</p>
            <p><bold>Breast and/or nipple hypoplasia</bold> is seen commonly with almost all individuals having nipple aplasia or hypoplasia and 90% of females having mammary gland aplasia or hypoplasia. This feature is characteristic of ADULT and limb-mammary syndrome and NOT typically seen in other <italic toggle="yes">TP63-</italic>related disorders.</p>
            <p><bold>Lacrimal duct atresia</bold> is seen in about half leading to chronic conjunctivitis and blepharitis, which are often not recognized until early childhood [<xref ref-type="bibr" rid="aec.REF.van_bokhoven.1999.538">van Bokhoven et al 1999</xref>].</p>
            <p>
              <bold>Ectodermal defects</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Nail</bold>
<bold>dysplasia</bold> is reported in 30% of individuals.</p>
              </list-item>
              <list-item>
                <p><bold>Dental anomalies.</bold> Hypodontia (reduced number of teeth) also become evident during childhood and adolescence and is seen in 10%-15%.</p>
              </list-item>
            </list>
            <p>Note: Skin and hair abnormalities are NOT typically seen, in contrast to other <italic toggle="yes">TP63-</italic>related disorders.</p>
            <p><bold>Cleft lip with or without cleft palate</bold> is present in 25%-30% and can include submucous cleft palate only, cleft of the soft and/or the hard palate only, cleft lip only, or the combination of cleft lip and cleft palate.</p>
          </sec>
          <sec id="aec.SHFM4">
            <title>SHFM4</title>
            <p>The manifestations of split-hand/foot malformation-4 (SHFM4) are typically present at birth.</p>
            <p><bold>Limb abnormalities</bold> include median clefts of the hands and feet; aplasia/hypoplasia of phalanges, metacarpals, and metatarsals; and some syndactyly.</p>
            <p><bold>Ectodermal abnormalities and cleft lip/palate</bold> are considered to be exclusion criteria for making the diagnosis SHFM4.</p>
          </sec>
          <sec id="aec.Orofacial_Cleft_8">
            <title>Orofacial Cleft 8</title>
            <p><xref ref-type="bibr" rid="aec.REF.leoyklang.2006.e28">Leoyklang et al [2006]</xref> have investigated the occurrence of <italic toggle="yes">TP63</italic> pathogenic variants in a cohort of 100 Thai patients <bold>with nonsyndromic CL/P</bold>. In total, 21 variant sites were identified. All were single nucleotide changes, with six in coding regions, including three novel nonsynonymous changes. No other features of <italic toggle="yes">TP63-</italic>related disorders were observed in these patients</p>
          </sec>
        </sec>
        <sec id="aec.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Note: Pathogenic variants have been described on two <italic toggle="yes">TP63</italic> isoforms: the TAp63&#x003b1; isoform, encoded by NM_003722.4, and the &#x00394;Np63&#x003b1; isoform, encoded by NM_001114982.1, which is 39 amino acids shorter and has an alternate N-terminal TA domain. See <xref ref-type="sec" rid="aec.Molecular_Genetics">Molecular Genetics</xref> and <xref ref-type="fig" rid="aec.F1">Figure 1</xref> for details.</p>
          <p><bold>AEC syndrome.</bold> All pathogenic variants associated with AEC syndrome occur in either the sterile alpha motif (SAM) domain (82%) or the &#x00394;Np63-specific N-terminal domain (18%). Pathogenic variants in the N-terminal domain that introduce premature termination codons lead to the use of an alternative start codon [<xref ref-type="bibr" rid="aec.REF.rinne.2008.1968">Rinne et al 2008</xref>] and to the consequent production of &#x00394;Np63&#x003b1; isoforms lacking the N-terminal domain, which are specifically associated with AEC syndrome. This isoform of p63 is the predominant isoform in mature epidermis, and it has been shown to repress ZNF750, leading to impaired epidermal differentiation [<xref ref-type="bibr" rid="aec.REF.zarnegar.2012.435">Zarnegar et al 2012</xref>].</p>
          <p><bold>ADULT syndrome</bold> is typically associated with pathogenic variants in the DNA binding domain at p.Arg337 (TAp63&#x003b1;; formerly known as p.Arg298), such as c.1009C&#x0003e;G (p.Arg337Gly) and c.1010G&#x0003e;A (p.Arg337Gln). Other pathogenic variants have been reported in isolated patients with features reminiscent of ADULT syndrome, but also of other <italic toggle="yes">TP63</italic>-associated syndromes. Examples include c.16A&#x0003e;C (p.Asn6His in &#x00394;Np63&#x003b1;), which is in an alternative TA domain and c.518G&#x0003e;T (p.Gly173Asp in TAp63&#x003b1;) which is between the TA and DNA binding domains [<xref ref-type="bibr" rid="aec.REF.rinne.2006b.904">Rinne et al 2006b</xref>, <xref ref-type="bibr" rid="aec.REF.rinne.2007.262">Rinne et al 2007</xref>], and c.497C&#x0003e;T (p.Pro166Leu in TAp63&#x003b1;) [<xref ref-type="bibr" rid="aec.REF.van_zelststams.2009.1558">van Zelst-Stams &#x00026; van Steensel 2009</xref>].</p>
          <p><bold>EEC3.</bold> All EEC pathogenic variants are missense variants in the DNA binding domain and have been demonstrated to disrupt DNA binding [<xref ref-type="bibr" rid="aec.REF.rinne.2006b.904">Rinne et al 2006b</xref>]. Splice changes and frameshifts associated with EEC have been reported [<xref ref-type="bibr" rid="aec.REF.celli.1999.143">Celli et al 1999</xref>, <xref ref-type="bibr" rid="aec.REF.van_bokhoven.2001.481">van Bokhoven et al 2001</xref>, <xref ref-type="bibr" rid="aec.REF.barrow.2002.559">Barrow et al 2002</xref>, <xref ref-type="bibr" rid="aec.REF.monti.2013.894">Monti et al 2013</xref>].</p>
          <p><bold>Limb-mammary syndrome.</bold> Limb-mammary syndrome is caused by pathogenic missense variants that are located between the transactivation domain and the DNA binding domain (p.Gly115, p.Ser129, and p.Gly173 residues in TAp63&#x003b1;) or by truncating variants in the SAM domain of <italic toggle="yes">TP63</italic> [<xref ref-type="bibr" rid="aec.REF.van_bokhoven.2001.481">van Bokhoven et al 2001</xref>, <xref ref-type="bibr" rid="aec.REF.rinne.2007.262">Rinne et al 2007</xref>].</p>
          <p><bold>SHFM4.</bold> Pathogenic missense variants in the TA and DNA binding domains have been associated with SHFM4 [<xref ref-type="bibr" rid="aec.REF.rinne.2007.262">Rinne et al 2007</xref>].</p>
          <p><bold>Isolated cleft lip/cleft palate (orofacial cleft 8)</bold> has been associated with <italic toggle="yes">TP63</italic> variants in the DNA binding domain [<xref ref-type="bibr" rid="aec.REF.leoyklang.2006.e28">Leoyklang et al 2006</xref>]. Of these variants, p.Arg352Gly in TAp63&#x003b1; was concluded to be pathogenic on the basis of its amino acid change, evolutionary conservation, its occurrence in a functionally important domain, its predicted damaging function, its <italic toggle="yes">de novo</italic> occurrence, and its absence in 500 control individuals.</p>
          <p>See <xref ref-type="fig" rid="aec.F1">Figure 1</xref>.</p>
        </sec>
        <sec id="aec.Penetrance">
          <title>Penetrance</title>
          <p>Reduced penetrance or possible germline mosaicism has been documented in a small number of individuals and families.</p>
          <p>Reduced penetrance for split-hand/foot malformation type 4 (SHFM4) [<xref ref-type="bibr" rid="aec.REF.spranger.1988.202">Spranger &#x00026; Schapera 1988</xref>] and ADULT syndrome [<xref ref-type="bibr" rid="aec.REF.amiel.2001.642">Amiel et al 2001</xref>] has been reported.</p>
          <p>A few individuals who do not appear to be clinically affected have had more than one child with AEC syndrome. These occurrences may be the result of reduced penetrance, but are more likely caused by somatic and germline mosaicism in one parent.</p>
          <p>In one family, the <italic toggle="yes">TP63</italic> pathogenic variant present in affected fraternal twins was seen in the phenotypically normal mother. The data suggested somatic mosaicism in the mother [van Bokhoven, unpublished data] with presumed germline mosaicism.</p>
        </sec>
        <sec id="aec.Nomenclature">
          <title>Nomenclature</title>
          <p>Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome is also known as Hay-Wells syndrome after the physicians who first described the condition in 1976.</p>
          <p>Rapp-Hodgkin syndrome (RHS), once considered a separate entity, is now considered to be part of the spectrum of the AEC syndrome because of the overlap of clinical manifestations and <italic toggle="yes">TP63</italic> pathogenic variants in the two conditions [<xref ref-type="bibr" rid="aec.REF.cambiaghi.1994.97">Cambiaghi et al 1994</xref>, <xref ref-type="bibr" rid="aec.REF.mcgrath.2001.221">McGrath et al 2001</xref>].</p>
          <p>EEC3 is thought to be genetically unrelated to EEC1 (which has been mapped to chromosome 7q11q21). An entity called EEC2 was initially mapped to chromosome 19 [<xref ref-type="bibr" rid="aec.REF.o_quinn.1998.130">O&#x02019;Quinn et al 1998</xref>]; however pathogenic variants in <italic toggle="yes">TP63</italic> were ultimately identified [<xref ref-type="bibr" rid="aec.REF.celli.1999.143">Celli et al 1999</xref>].</p>
        </sec>
        <sec id="aec.Prevalence">
          <title>Prevalence</title>
          <p><italic toggle="yes">TP63-</italic>related disorders are rare. The prevalence of disorders individually or collectively is unknown.</p>
        </sec>
      </sec>
      <sec id="aec.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">TP63</italic>.</p>
      </sec>
      <sec id="aec.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <sec id="aec.AEC_Syndrome_1">
          <title>AEC Syndrome</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter"><bold>Epidermolysis bullosa</bold></related-object><bold>.</bold> Because of the presence of skin erosions at birth, many affected individuals are misdiagnosed with <related-object link-type="booklink" source-id="gene" document-id="ebs" document-type="chapter">epidermolysis bullosa</related-object>; however, the erosions of AEC syndrome are typically more superficial and not associated with formation of bullae. In addition to the non-dermatologic phenotypic differences, dermatopathology should distinguish epidermolysis bullosa from AEC syndrome. The presence of erythroderma with a collodion membrane can also lead to an initial misdiagnosis of <related-object link-type="booklink" source-id="gene" document-id="li-ar" document-type="chapter">ichthyosis</related-object> in the newborn period [<xref ref-type="bibr" rid="aec.REF.siegfried.2005.1591">Siegfried et al 2005</xref>].</p>
          <p><bold>Curly hair-ankyloblepharon-nail dysplasia syndrome (CHANDS)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/214350">OMIM</ext-link>) has the overlapping features of ankyloblepharon and hair changes, but it does not typically include the significant facial/oral clefting or skin erosions that are virtually universal in AEC syndrome.</p>
        </sec>
        <sec id="aec.EEC3">
          <title>EEC3</title>
          <p>EEC1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/129900">OMIM</ext-link>) is suspected to be caused by pathogenic variants in a gene on chromosome 7q21q22 based on a series of individuals with various cytogenetically visible chromosomal abnormalities.</p>
          <p>Other EEC syndrome-like phenotypes that do not appear to involve the EEC1 and EEC3 loci have been described.</p>
        </sec>
        <sec id="aec.SHFM4_1">
          <title>SHFM4</title>
          <p><bold>SHFM1</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/183600">OMIM</ext-link>) is caused by deletions of chromosome 7q21 involving <italic toggle="yes">DLX5</italic> and <italic toggle="yes">DLX6</italic> as well as homozygous pathogenic variants in <italic toggle="yes">DLX5</italic> and is associated with a high incidence of hearing loss. Findings in this disorder are largely restricted to the limbs. Dental and lacrimal duct abnormalities are seen in fewer than 10% of individuals [<xref ref-type="bibr" rid="aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</xref>].</p>
          <p><bold>SHFM2</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/313350">OMIM</ext-link>) has been mapped to Xq26 and while both males and females are affected, males tend to have a more severe phenotype. Cleft lip/palate and ectodermal defects are not seen in this condition.</p>
          <p><bold>SHFM3</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/246560">OMIM</ext-link>) is caused by a contiguous gene duplication on chromosome 10q24 and does not have lacrimal, dental, or ectodermal abnormalities (beyond nail abnormalities associated with developmental defects of the digits) [<xref ref-type="bibr" rid="aec.REF.de_mollerat.2003.1959">de Mollerat et al 2003</xref>, <xref ref-type="bibr" rid="aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</xref>].</p>
          <p><bold>SHFM5</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/606708">OMIM</ext-link>) is caused by deletions of chromosome 2q31. Abnormally shaped teeth may be present, but neither oligodontia nor other ectodermal defects that may be seen in SHFM4 are reported. Dysmorphic facial features tend to be present [<xref ref-type="bibr" rid="aec.REF.elliott.2006.1419">Elliott &#x00026; Evans 2006</xref>].</p>
          <p><bold>SHFM6</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/225300">OMIM</ext-link>) has been attributed to homozygous pathogenic variants in <italic toggle="yes">WNT10B</italic>. Interestingly, all but one of the affected individuals in the initial pedigree also had promoter polymorphism in <italic toggle="yes">TP63</italic> [<xref ref-type="bibr" rid="aec.REF.ugur.2008.2644">Ugur &#x00026; Tolun 2008</xref>].</p>
        </sec>
        <sec id="aec.TP63Related_Disorders_Generally">
          <title><italic toggle="yes">TP63</italic>-Related Disorders Generally</title>
          <p><related-object link-type="booklink" source-id="gene" document-id="x-hed" document-type="chapter"><bold>Hypohidrotic ectodermal dysplasia</bold></related-object>
<bold>(HED)</bold> is characterized by hypotrichosis (sparseness of scalp and body hair), hypohidrosis (reduced ability to sweat), and hypodontia (congenital absence of teeth). In HED the hypohidrosis is severe enough to impair body temperature regulation, a problem not seen in AEC syndrome. Orofacial clefting, universal in AEC syndrome, is not typically seen in HED.</p>
        </sec>
      </sec>
      <sec id="aec.Management">
        <title>Management</title>
        <sec id="aec.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">TP63</italic> related disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical genetics to aid in diagnosis, coordination of health surveillance, and genetic testing and counseling</p>
            </list-item>
            <list-item>
              <p>Dermatology to evaluate and treat related skin issues, especially erosions</p>
            </list-item>
            <list-item>
              <p>Gastroenterology for growth and nutrition issues</p>
            </list-item>
            <list-item>
              <p>Dietary if there are concerns about failure to thrive</p>
            </list-item>
            <list-item>
              <p>Ophthalmology for evaluation and treatment of ocular issues including ankyloblepharon, lacrimal duct atresia/obstruction, dry eyes and blepharitis</p>
            </list-item>
            <list-item>
              <p>Plastic surgery to evaluate and repair cleft lip and palate or breast/nipple assymetry</p>
            </list-item>
            <list-item>
              <p>Otolaryngology for evaluation and treatment of recurrent otitis media and speech issues</p>
            </list-item>
            <list-item>
              <p>Audiology to evaluate for hearing loss</p>
            </list-item>
            <list-item>
              <p>Dental to evaluate and address issues of hypodontia</p>
            </list-item>
            <list-item>
              <p>Prosthodontics to address potential need for dental implants</p>
            </list-item>
            <list-item>
              <p>Psychology/psychiatry to address developmental issues and provide support for the individual and family by assisting in dealing with the impact of the phenotype on a normal life</p>
            </list-item>
          </list>
        </sec>
        <sec id="aec.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A multidisciplinary approach is recommended including regular evaluations with specialists in clinical genetics, dermatology, ophthalmology, otolaryngology, audiology, dentistry and prosthodontics, plastic surgery, gastroenterology, and psychiatry.</p>
          <p><bold>Ankyloblepharon filiforme adnatum.</bold> These strands of tissue between the upper and lower eyelids are often small and autolyse shortly after birth; larger ones may require surgical separation by an ophthalmologist.</p>
          <p>
            <bold>Ectodermal defects</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Wigs can be used, if desired, for the sparse hair and alopecia.</p>
            </list-item>
            <list-item>
              <p>There are no known therapies for the nail or skin pigment changes.</p>
            </list-item>
            <list-item>
              <p>Dentures should be considered in early childhood and the possibility of dental implants should be considered in the teens or early adult years.</p>
            </list-item>
            <list-item>
              <p>Sweating is not severely impaired and does not require special care.</p>
            </list-item>
          </list>
          <p><bold>Skin erosions.</bold> The skin erosions are difficult to treat and prone to excessive ineffective granulation response; they are at increased risk for secondary infection and are not responsive to most standard wound care regimens or antibiotic therapy [<xref ref-type="bibr" rid="aec.REF.julapalli.2009.1900">Julapalli et al 2009</xref>]. Skin erosions should be treated with gentle wound care and periodic, dilute bleach soaks (Dakins solution) to prevent secondary infection.</p>
          <p>Occlusive dressings should <bold>not</bold> be used as they tend to stimulate granulation tissue.</p>
          <p>Secondary infections should be treated with topical or oral antibiotics or antifungal agents when appropriate. Empiric treatment (i.e., use of antibiotic without culture-proven infection) is not recommended.</p>
          <p><bold>Cleft lip/palate.</bold> Clefting should be addressed as soon as developmentally possible. Typical feeding issues associated with clefting are seen and include: poor suck, difficulty coordinating feeding and breathing, and excessive air intake. A nurse, nutritionist, pediatrician, speech therapist, or other specialist familiar with the management of feeding issues in children with cleft lip/palate should be consulted. Early referral to a craniofacial surgeon for planning for surgical cleft repair is indicated.</p>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Weight should be followed closely with assessment for signs of failure to thrive. If optimization of oral caloric intake fails to improve growth, gastrostomy tube placement may be considered.</p>
            </list-item>
            <list-item>
              <p>Myringotomy is indicated as needed for conductive hearing loss resulting from chronic otitis media.</p>
            </list-item>
            <list-item>
              <p>Significant breast asymmetry in women may be corrected through plastic surgery.</p>
            </list-item>
            <list-item>
              <p>Psychological impact of the phenotypic features of the disorder on patient and family should also be considered and referrals made to psychiatry or psychology as appropriate.</p>
            </list-item>
          </list>
        </sec>
        <sec id="aec.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Infants with severe skin erosions should be monitored and treated aggressively for dehydration, electrolyte imbalances, malnutrition, and secondary infection and sepsis.</p>
        </sec>
        <sec id="aec.Surveillance">
          <title>Surveillance</title>
          <p>Regular evaluation with a multidisciplinary team is recommended for evaluation and prompt treatment of disease manifestations. In particular:</p>
          <list list-type="bullet">
            <list-item>
              <p>Dental findings over time may warrant use of dental prosthetics.</p>
            </list-item>
            <list-item>
              <p>Periodic hearing evaluations should be performed as conductive hearing loss is common.</p>
            </list-item>
          </list>
        </sec>
        <sec id="aec.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Prolonged exposure to sunlight should be avoided to prevent sunburn of hypopigmented areas and to prevent increasing the contrast between the patchy areas of hyper- and hypopigmentation seen in AEC syndrome. Reduced sun exposure can minimize freckling of skin in individuals with ADULT syndrome.</p>
        </sec>
        <sec id="aec.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives of an affected individual by molecular genetic testing of the <italic toggle="yes">TP63</italic> pathogenic variant in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>See <xref ref-type="sec" rid="aec.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="aec.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>No specific trials for therapies are being conducted at this time. An investigational product developed to activate mutated p53 in cancer therapy has been tested for its ability to activate mutated p63 protein carrying EEC3-associated amino acid substitutions. This compound, denoted APR-246/PRIMA-1MET, showed a beneficial effect on skin differentiation [<xref ref-type="bibr" rid="aec.REF.shalomfeuerstein.2013.2152">Shalom-Feuerstein et al 2013</xref>, <xref ref-type="bibr" rid="aec.REF.shen.2013.2157">Shen et al 2013</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="aec.Other">
          <title>Other</title>
          <p>The National Foundation for Ectodermal Dysplasias (NFED) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nfed.org">www.nfed.org</ext-link>) is an excellent resource for affected individuals, their families, and clinicians who care for these individuals.</p>
        </sec>
      </sec>
      <sec id="aec.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="aec.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>The <italic toggle="yes">TP63</italic>-related disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="aec.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 30% of individuals diagnosed with AEC have an affected parent. This appears to be true for the other <italic toggle="yes">TP63</italic>-related disorders as well [van Bokhoven H, Bree AF, Sutton VR; unpublished data].</p>
            </list-item>
            <list-item>
              <p>A proband with a <italic toggle="yes">TP63</italic>-related disorder may have the disorder as the result of a new pathogenic variant. The proportion of individuals with AEC caused by a <italic toggle="yes">de novo</italic>
<italic toggle="yes">TP63</italic> pathogenic variant is approximately 70%. This appears to be true for the other <italic toggle="yes">TP63</italic>-related disorders as well [van Bokhoven H, Bree AF, Sutton VR; unpublished data].If the <italic toggle="yes">TP63</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or a <italic toggle="yes">de novo</italic> pathogenic variant in the proband.</p>
              <list list-type="bullet">
                <list-item>
                  <p>In one family, the <italic toggle="yes">TP63</italic> pathogenic variant present in fraternal twins was identified in the phenotypically normal mother. Further study of the mother suggested somatic and germline mosaicism [van Bokhoven, unpublished data].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with a <italic toggle="yes">TP63</italic>-related disorder may appear to be negative because of failure to recognize the disorder in family members. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (physical exam and molecular genetic testing) have been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected and/or the <italic toggle="yes">TP63</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">TP63</italic>-related disorder has a 50% chance of inheriting the <italic toggle="yes">TP63</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband&#x02019;s parents: if a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="aec.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="aec.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with a <italic toggle="yes">TP63</italic>-related disorder has the pathogenic variant or clinical evidence of the disorder<bold>,</bold> the <italic toggle="yes">TP63</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="aec.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">TP63</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for a <italic toggle="yes">TP63</italic>-related disorder are possible options.</p>
          <p>Requests for prenatal testing for conditions which (like the <italic toggle="yes">TP63</italic>-related disorders) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="aec.Resources">
        <title>Resources</title>
      </sec>
      <sec id="aec.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> Many <italic toggle="yes">TP63</italic> transcripts encoding different proteins have been reported but the biologic validity and the full-length nature of these variants have not been determined [NCBI RefSeq]. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gene/8626?ordinalpos=1&#x00026;itool=EntrezSystem2.PEntrez.Gene.Gene_ResultsPanel.Gene_RVDocSum">NCBI Gene</ext-link> for <italic toggle="yes">TP63</italic> transcript variants. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="aec" object-id="aec.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p>The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/169234655">NM_003722.4</ext-link> has 16 exons and is the longest <italic toggle="yes">TP63</italic> transcript; it encodes the longest protein, isoform 1 (also known as TAp63&#x003b1;, KET, and p51B). The transcript variant (6), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001114982.1">NM_001114982.1</ext-link>, differs in the 5&#x02032; UTR and coding region, and in the 3&#x02032; UTR and coding region, compared to variant 1. The resulting protein (isoform 6, also known as &#x00394;Np63&#x003b3;) is shorter and has distinct N- and C-termini, compared to isoform 1.</p>
        <p>Note: The nomenclature for <italic toggle="yes">TP63</italic> pathogenic variants is problematic. The reason for confusion is that the reference sequence for <italic toggle="yes">TP63</italic> has been changed over the years. The original reference sequence for TAp63&#x003b1; was defined by the cDNA with accession number AF075430, which encodes a protein of 641 amino acids. This is the cDNA reported in <xref ref-type="bibr" rid="aec.REF.yang.1998.305">Yang et al [1998]</xref>. The numbering of pathogenic variants is based on this clone (except for those that are specific for the &#x00394;N 5&#x02032; end, which are based on <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001114982.1">NM_001114982.1</ext-link>). <xref ref-type="bibr" rid="aec.REF.yang.1998.305">Yang et al [1998]</xref> also reported a protein with an extended 5&#x02032; end, which they denoted TA*p63alpha. This protein encodes an additional 39 amino acids at the N-terminal end, resulting in a protein with a total of 680 amino acids. Later, this cDNA/protein (accession <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/169234655">NM_003722.4</ext-link>) became the reference sequence for TAp63&#x003b1;. Taking this sequence as a reference, all previously reported pathogenic variants should also be renamed by adding 39 amino acids. For example, p.Arg298Gly would be p.Arg337Gly (<xref ref-type="table" rid="aec.T.selected_tp63_pathogenic_variants">Table 3</xref>).</p>
        <p><bold>Pathogenic allelic variants.</bold> Heterozygous pathogenic variants in <italic toggle="yes">TP63</italic> cause AEC syndrome, ADULT syndrome, EEC3, Limb-mammary syndrome, and SHFM4 (see <xref ref-type="sec" rid="aec.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
        <table-wrap id="aec.T.selected_tp63_pathogenic_variants" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">TP63</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.16A&#x0003e;C</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asn6His</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001114982.1">NM_001114982.1</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001108454.1">NP_001108454.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.497C&#x0003e;T</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro166Leu</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003722.4">NM_003722.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003713.3">NP_003713.3</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.518G&#x0003e;A</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly173Asp<break/>(Gly134Asp)&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1009C&#x0003e;G</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg337Gly<break/>(Arg298Gly)&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1010G&#x0003e;A</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg337Gln <break/>(Arg298Gln)&#x000a0;<sup>2</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1054A&#x0003e;G</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg342Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1963delC</td>
                <td headers="hd_h_aec.T.selected_tp63_pathogenic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg655GlufsTer49</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="aec.TF.3.1">
              <label>1. </label>
              <p>Variant designation that does not conform to current naming conventions</p>
            </fn>
            <fn id="aec.TF.3.2">
              <label>2. </label>
              <p>In these instances, alias nomenclature is based on sequence AF075430.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> This gene encodes a member of the p53 family of transcription factors. The transcript variant NM_003722.4 is the longest <italic toggle="yes">TP63</italic> transcript and encodes the longest protein of 680 amino acid residues (isoform 1, also known as TAp63&#x003b1;, KET, and p51B). The transcript variant <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001114982.1">NM_001114982.1</ext-link> encodes isoform 6, also known as &#x00394;Np63&#x003b3; (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001108454.1">NP_001108454.1</ext-link>), which is shorter and has distinct N- and C-termini, compared to isoform 1.</p>
        <p><bold>Abnormal gene product.</bold> TP63 is a master regulator of the embryonic development and differentiation of ectodermal cells [<xref ref-type="bibr" rid="aec.REF.shalomfeuerstein.2013.2152">Shalom-Feuerstein et al 2013</xref>]. Additionally, it plays a critical role in the development of the apical ectodermal ridge of the limb bud in collaboration with the signaling molecule FGF8 [<xref ref-type="bibr" rid="aec.REF.restelli.2014.3830">Restelli et al 2014</xref>].</p>
      </sec>
      <sec id="aec.References">
        <title>References</title>
        <sec id="aec.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="aec.Literature_Cited.reflist0">
            <ref id="aec.REF.amiel.2001.642">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougeard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francannet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raclin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frebourg</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>TP63 gene mutation in ADULT syndrome.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2001</year>
                <volume>9</volume>
                <fpage>642</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11528512</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.aradhya.2012.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aradhya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nwokekeh</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stafford</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boggs</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hruska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smaoul</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compton</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suchy</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders.</article-title>
                <source>Genet Med</source>
                <volume>14</volume>
                <fpage>594</fpage>
                <lpage>603</lpage>
                <pub-id pub-id-type="pmid">22382802</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.barrow.2002.559">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barrow</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daack-Hirsch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beersum</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorlin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts.</article-title>
                <source>J Med Genet.</source>
                <year>2002</year>
                <volume>39</volume>
                <fpage>559</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">12161593</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.bertola.2004.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertola</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albano</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Molecular evidence that AEC syndrome and Rapp-Hodgkin syndrome are variable expression of a single genetic disorder.</article-title>
                <source>Clin Genet</source>
                <year>2004</year>
                <volume>66</volume>
                <fpage>79</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">15200513</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.buss.1995.716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buss</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Twenty-four cases of the EEC syndrome: clinical presentation and management.</article-title>
                <source>J Med Genet.</source>
                <year>1995</year>
                <volume>32</volume>
                <fpage>716</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">8544192</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.cambiaghi.1994.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cambiaghi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbareschi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Rapp-Hodgkin syndrome and AEC syndrome: Are they the same entity?</article-title>
                <source>Br J Dermatol</source>
                <volume>130</volume>
                <fpage>97</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">8305327</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.celli.1999.143">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Celli</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duijf</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smits</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Buggenhout</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haeringen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woods</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Essen</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Waal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vriend</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haber</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome.</article-title>
                <source>Cell.</source>
                <year>1999</year>
                <volume>99</volume>
                <fpage>143</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">10535733</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.cole.2009.1910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatef</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magruder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sindwani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hollier</surname>
                    <given-names>LH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Facial clefting and oroauditory pathway manifestations in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>149A</volume>
                <fpage>1910</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19697430</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.de_mollerat.2003.1959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Mollerat</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sangiorgi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everman</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blouin</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allanson</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Marec</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>NE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radhakrishna</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delozier-Blanchet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbott</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elghouzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonarakis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <article-title>A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>1959</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12913067</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.dishop.2009.1935">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dishop</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hicks</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pathologic changes of skin and hair in ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>149A</volume>
                <fpage>1935</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">19697429</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.elliott.2006.1419">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elliott</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlations in mapped split hand foot malformation (SHFM) patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>1419</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">16688749</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.farrington.2009.1907">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrington</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lausten</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Oral findings in ankyloblepharon-ectodermal dysplasia-cleft lip/palate (AEC) syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>149A</volume>
                <fpage>1907</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19681142</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.julapalli.2009.1900">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Julapalli</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scher</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sybert</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegfried</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>AF</given-names>
                  </name>
                </person-group>
                <article-title>Dermatologic findings of ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009</year>
                <volume>149A</volume>
                <fpage>1900</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19681128</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.lane.2009.1926">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lane</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dalton</surname>
                    <given-names>WT</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czyzewski</surname>
                    <given-names>DI</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Psychosocial functioning and quality of life in children and families affected by AEC syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>1926</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">19504609</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.leoyklang.2006.e28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leoyklang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siriwan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shotelersuk</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A mutation of the p63 gene in non-syndromic cleft lip.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>e28</fpage>
                <pub-id pub-id-type="pmid">16740912</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.mcgrath.2001.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duijf</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doetsch</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Waal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wessagowit</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atherton</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlow</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haeringen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ausems</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of TP63.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>221</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11159940</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.monti.2013.894">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bocciardi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foggetti</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menichini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Divizia</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerone</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graziano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wischmeijer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viadiu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravazzolo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fronza</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences.</article-title>
                <source>Hum Mutat.</source>
                <year>2013</year>
                <volume>34</volume>
                <fpage>894</fpage>
                <lpage>904</lpage>
                <pub-id pub-id-type="pmid">23463580</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.motil.2009.1922">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Motil</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fete</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Growth, nutritional, and gastrointestinal aspects of ankyloblepharon-ectodermal defect-cleft lip and/or palate (AEC) syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>1922</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19676058</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.o_quinn.1998.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>O&#x02019;Quinn</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorde</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Syndromic ectrodactyly with severe limb, ectodermal, urogenital, and palatal defects maps to chromosome 19.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1998</year>
                <volume>62</volume>
                <fpage>130</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9443880</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.pashayan.1974.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pashayan</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruzansky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>The EEC syndrome. Report of six patients.</article-title>
                <source>Birth Defects Orig Artic Ser.</source>
                <year>1974</year>
                <volume>10</volume>
                <fpage>105</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">4425508</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.restelli.2014.3830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Restelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopardo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lo Iacono</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garaffo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conte</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rustighi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Napoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Sal</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Morga</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costanzo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlo</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>DLX5, FGF8 and Pin1 isomerase control &#x00394;Np63&#x003b1; protein stability during limb development: a regulatory loop at the basis of the S?HFM and EEC congenital malformations.</article-title>
                <source>Hum Mol Genet</source>
                <volume>23</volume>
                <fpage>3830</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">24569166</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.rinne.2009.1948">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolat</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Spectrum of p63 mutations in a selected patient cohort with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>149A</volume>
                <fpage>1948</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">19676060</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.rinne.2007.262">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>p63-associated disorders.</article-title>
                <source>Cell Cycle</source>
                <volume>6</volume>
                <fpage>262</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17224651</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.rinne.2008.1968">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clements</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duijf</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolat</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meijer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGrath</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schalkwijk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes.</article-title>
                <source>Hum Mol Genet</source>
                <volume>17</volume>
                <fpage>1968</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">18364388</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.rinne.2006.1396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2006a</year>
                <article-title>Pattern of p63 mutations and their phenotypes--update.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>1396</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">16691622</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.rinne.2006b.904">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spadoni</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjaer</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danesino</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larizza</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kock</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huoponen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savontaus</surname>
                    <given-names>M-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aaltonen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duijf</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penttinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006b</year>
                <article-title>Delineation of the ADULT syndrome phenotype due to arginine 298 mutgations of the p63 gene.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>14</volume>
                <fpage>904</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">16724007</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.shalomfeuerstein.2013.2152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shalom-Feuerstein</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serror</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aberdam</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiman</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aberdam</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petit</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>2152</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23355677</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.shen.2013.2157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Bogaard</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kouwenhoven</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bykov</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinne</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tjabringa</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilissen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heeringen</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schalkwijk</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiman</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>2157</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">23355676</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.siegfried.2005.1591">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siegfried</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fete</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sybert</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Skin erosions and wound healing in ankyloblepharon-ectodermal defect &#x02013; cleft lip and/or palate.</article-title>
                <source>Arch Dermatol</source>
                <volume>141</volume>
                <fpage>1591</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16365264</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.spranger.1988.202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapera</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Anomalous inheritance in a kindred with split hand, split foot malformation.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>147</volume>
                <fpage>202</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">3366140</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.sutton.2009.1916">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plunkett</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dang</surname>
                    <given-names>DX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bree</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacino</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Craniofacial and anthropometric phenotype in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (Hay-Wells syndrome) in a cohort of 17 patients.</article-title>
                <source>Am J Med Genet A</source>
                <volume>149A</volume>
                <fpage>1916</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">19676059</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.ugur.2008.2644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ugur</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolun</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Homozygous WNT10b mutation and complex inheritance in Split-Hand/Foot Malformation.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2008</year>
                <volume>17</volume>
                <fpage>2644</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">18515319</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.van_bokhoven.2001.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sangiorgi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duijf</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beusekom</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beersum</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celli</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merkx</surname>
                    <given-names>GF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raas-Rotschild</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beemer</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crisponi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yates</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>481</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11462173</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.van_bokhoven.1999.538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smits</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beersum</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000fc;schendorf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veenstra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuerlings</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariman</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wienker</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                </person-group>
                <article-title>Limb mammary syndrome: a new genetic disorder with mammary hypoplasia, ectrodactyly, and other Hand/Foot anomalies maps to human chromosome 3q27.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1999</year>
                <volume>64</volume>
                <fpage>538</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">9973291</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.van_zelststams.2009.1558">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Zelst-Stams</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>A novel TP63 mutation in family with ADULT syndrome presenting with eczema and hypothelia.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009</year>
                <volume>149A</volume>
                <fpage>1558</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">19530185</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.yang.1998.305">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaghad</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillett</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000f6;tsch</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caput</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKeon</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.</article-title>
                <source>Mol Cell.</source>
                <volume>2</volume>
                <fpage>305</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">9774969</pub-id>
              </element-citation>
            </ref>
            <ref id="aec.REF.zarnegar.2012.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zarnegar</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Pajares</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vander Stoep Hunt</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berk</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sen</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khavari</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>91</volume>
                <fpage>435</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">22922031</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="aec.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="aec.Author_Notes">
          <title>Author Notes</title>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://findaphysician.bcm.edu/search/#/listing/1154">Dr Sutton&#x02019;s Web page</ext-link>
          </p>
          <p>
            <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.rimls.nl/people/b/bokhoven-van/">Dr van Bokhoven&#x02019;s Web page</ext-link>
          </p>
        </sec>
        <sec id="aec.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors would like to thank the National Foundation for Ectodermal Dysplasias and Executive Director Mary Fete, who organized the International Research Symposium on AEC syndrome, and all the individuals and families who participated in the research that contributed to this review. Additionally, we would like to express our gratitude to Dr John Carey and the American Journal of Medical Genetics for publishing these research results in a unified special issue of the journal.</p>
        </sec>
        <sec id="aec.Author_History">
          <title>Author History</title>
          <p>Alanna F Bree, MD; Dermatology Specialists of Houston (2010-2015)V Reid Sutton, MD (2010-present)Hans van Bokhoven, PhD (2010-present)</p>
        </sec>
        <sec id="aec.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 August 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 June 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>2 February 2010 (vrs) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="aec.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Typical and common <italic toggle="yes">TP63</italic> pathogenic variants identified in various disorders as indicated by color key. Pathogenic variants indicated by * are specific for the &#x00394;Np63&#x003b1; isoform and their numbering is based on the respective reference sequences (NM_001114982.1, NP_001108454.1). The numbering of other pathogenic variants is based on the reference sequences for TAp63&#x003b1; (NM_003722.4, NP_003713.3). Note that the variant indicated by # (R97C) is specific for TAp63&#x003b1;.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="aec-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
